Go to PubMed and copy the title in the search field.
The multifaceted therapeutic potential of benfotiamine.
Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.
Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.
Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt FoxO signaling.
Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
Benfotiamine in the treatment of diabetic polyneuropathy–a three-week randomized, controlled pilot study (BEDIP study).
Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy.
A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy.
Peripheral neuropathy: pathogenic mechanisms and alternative therapies.